210TiPIMbrave150: A randomised phase III study of atezolizumab + bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma. (25th November 2018) - Qin, S; Cheng, A-L; Ducreux, M P; Galle, P R; Zhu, A; Kim, T-Y; Xu, D-Z; Verret, W; Liu, J; Finn, R S; Ikeda, M